The EAT study recruited a cohort of 1303 three-month-old infants who were both geographically and demographically representative of the population of England and Wales (Table II).14, 21, 23, 24, 25, 26, 27 The prevalence of visible eczema at the 3-month enrollment visit was 24.4%, and filaggrin mutation carriage was 11.9%. This evidence concerns the gene FLG and Eczematoid dermatitis.